Odyssey Therapeutics Inc.
ODTX | NASDAQ
$19.43
-$0.11 (-0.56%)
Nov 2, 2026, 12:38 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 |
|---|---|
Net Income | -148.65M |
Depreciation & Amortization | 4.91M |
Stock-Based Compensation | 14.32M |
Other Working Capital | -6.79M |
Other Non-Cash Items | 4.67M |
Deferred Income Tax | n/a |
Change in Working Capital | -4.73M |
Operating Cash Flow | -129.47M |
Capital Expenditures | -1.23M |
Cash Acquisitions | n/a |
Purchase of Investments | -208.97M |
Sales Maturities Of Investments | 105.9M |
Other Investing Acitivies | 357K |
Investing Cash Flow | -103.94M |
Debt Repayment | n/a |
Common Stock Repurchased | n/a |
Dividend Paid | n/a |
Other Financial Acitivies | n/a |
Financial Cash Flow | 215.65M |
Net Cash Flow | -17.45M |
Free Cash Flow | -130.7M |
Adj. Free Cash Flow | -145.02M |
Maintenance CapEx | -1.23M |
Growth CapEx | n/a |
Owner Earnings | -130.7M |
Add to Watchlist
Select watchlists to add or remove ODTX